Lipoprotein (a)[Lp (a)] has attracted the interest of researchers and physicians due to its
intriguing properties, including an intragenic multiallelic copy number variation in the LPA …

Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular
Mortality - PMC Back to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage …

Plasma lipoprotein (a)[L p (a)] is a quantitative genetic trait with a very broad and skewed
distribution, which is largely controlled by genetic variants at the LPA locus on chromosome …

The synthesis of bioactive vitamin D requires hydroxylation at the 1α and 25 positions by
cytochrome P450 enzymes in the kidney and liver, respectively. The mitochondrial enzyme …

Abstract Lipoprotein (a)[Lp (a)] is a highly atherogenic lipoprotein that is under strong
genetic control by the LPA gene locus. Genetic variants including a highly polymorphic copy …

Objectives: The purpose of this study was to assess the association of apolipoprotein
(a)(apo [a]) isoforms with cardiovascular disease risk. Background: Although circulating …

Background Large-scale prospective data are needed to determine whether associations
between lipoprotein (a)(Lp [a]) and coronary heart disease (CHD) risk are independent of …

Objective—We aimed to examine associations of lipoprotein (a)(Lp (a)) concentrations with
coronary heart disease (CHD) and determine whether current Lp (a) clinical laboratory cut …

Lipoprotein (a)[Lp (a)], is present only in humans, Old World nonhuman primates, and the
European hedgehog. Lp (a) has many properties in common with low-density lipoprotein …

Lipoprotein (a)[Lp (a)] is a highly atherogenic lipid particle. Although earlier reports
suggested that Lp (a) levels are mostly determined by genetic factors, several recent studies …